放疗诱发的纤维性组织细胞瘤在乳腺癌患者中模拟局部复发并由18F-FDG PET/CT检出
一名76岁女性乳腺癌患者接受保乳手术及放化疗后,复查18F-FDG PET/CT未见异常;9个月后因右胸壁近原肿瘤床体检发现病灶再次行18F-FDG PET/CT,显示约1 cm结节性病灶FDG摄取强烈,疑为转移并建议病理确认,切除后病理诊断为良性细胞性纤维性组织细胞瘤。
要点
- 乳腺癌放化疗后胸壁近原肿瘤床出现FDG高摄取结节时,需鉴别放疗诱发的良性纤维性组织细胞瘤与局部复发。
- 18F-FDG PET/CT可检出约1 cm的放疗后纤维性组织细胞瘤病灶并表现为FDG摄取强烈,易被报告为转移可疑。
- 病理切除检查是确诊良性细胞性纤维性组织细胞瘤的依据。
核心结论
- 放疗诱发的良性细胞性纤维性组织细胞瘤可在18F-FDG PET/CT上表现为FDG摄取强烈,模拟乳腺癌局部复发。
研究设计与样本
- 个案报道:一名76岁女性乳腺癌患者,接受保乳手术和放化疗,治疗完成后1年复查18F-FDG PET/CT未见任何病理发现。
主要发现
- 治疗完成后1年复查18F-FDG PET/CT未检出任何病理发现。
- 因体检发现右胸壁近原肿瘤床病灶,9个月后再次行18F-FDG PET/CT,显示约1 cm结节性病灶FDG摄取强烈,报告为转移可疑并建议病理确认。
- 行切除术,病理检查诊断为良性细胞性纤维性组织细胞瘤。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A 76-year-old woman was diagnosed breast carcinoma and treated with breast-conserving surgery and chemoradiotherapy. A year after the treatment completion, restaging 18 F-FDG PET/CT scan detected no any pathological finding. However, due to a lesion detected during physical examination on the right thoracic wall adjacent to the primary tumor bed, 18 F-FDG PET/CT imaging was performed 9 months later for restaging. Highly intense FDG uptake was detected in an approximately 1-cm nodular lesion, and metastasis was reported as suspicious, and histopathological confirmation was recommended. Excision was performed and pathological examination diagnosed benign cellular fibrous histiocytoma.
引用
- Beytur MF, Alçın G, Cin S, et al. Radiation Therapy-Induced Fibrous Histiocytoma, Mimicking Local Recurrence and Detected by 18 F-FDG PET/CT in a Patient With Breast Cancer. Clin Nucl Med. 2024. PMID: 38914095. doi:10.1097/RLU.0000000000005320
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。